A disruptive Magnetically Enhanced Library preparation platform for Next Generation Sequencing

Project description

New lab device will democratise next-generation sequencing

Next generation sequencing (NGS) is a powerful new tool for biological and clinical research, but it remains inaccessible and unaffordable to smaller laboratories, clinics and companies due to low-reproducibility manual library preparations, expensive reagents, and scarce biological samples. MAGELIA is a new automated and miniaturised sample preparation platform for NGS at small scales. It requires sample volumes 100-1 000 times smaller than traditional NGS volumes in a completely automated platform for better reproducibility. MAGELIA aims to democratise NGS; in this phase, the project will accelerate time-to-market, increase funding for commercialisation, and reach out to a broad potential customer base.

Fields of science

• natural sciences › physical sciences › classical mechanics › fluid mechanics › microfluidics
• social sciences › political sciences › political transitions › revolutions
• medical and health sciences › basic medicine › pharmacology and pharmacy

Programme(s)

• H2020-EU.2.3. - INDUSTRIAL LEADERSHIP - Innovation In SMEs Main Programme
• H2020-EU.3. - PRIORITY 'Societal challenges
• H2020-EU.2.1. - INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies

Topic(s)

• EIC-SMEInst-2018-2020 - SME instrument

Call for proposal

H2020-EIC-SMEInst-2018-2020

See other projects for this call

Sub call

H2020-SMEInst-2018-2020-2

Funding Scheme

SME-2 - SME instrument phase 2

Coordinator

INOREVIA

Net EU contribution

€ 1 955 100,00

Address

29 Rue Du Faubourg Saint-jacques
75014 Paris
France

Region

Ile-de-France › Ile-de-France › Paris

Activity type

Private for-profit entities (excluding Higher or Secondary Education Establishments)

Links

Other funding

€ 837 900,00